|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of atorvastatin on the pharmacokineties and pharmacodynamics of prasugrel and clopidogrel in healthy subjects显示文摘 | Farid NA Small DS Payne CD | 2008 | Pharmacotherapy2008，28，12： | 1 |
| 2 | Effects of the proton pump inhibitor lansoprazole on the pharmaeokinetic and pha- maeodynamics of prasugrel and clopidogrel显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Phama- col2008，48，4： | 1 |
| 3 | Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel显示文摘 | Small DS Farid NA Li YG | 2008 | Curr Med Res Opin2008，24，8： | 1 |
| 4 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 5 | Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel显示文摘 | Small DS Farid NA Li YG | 2008 | Curr Med Res Opin2008，24，8： | 1 |
| 6 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel 显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 7 | Interactions of two major metabolites of Prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450 显示文摘 | Rehmel JL Eckstein JA Farid NA | 2006 | Drug Metab Dispos2006，34，4： | 1 |
| 8 | Interactions of two major metabolites of prasugrel,a thienopyridine antiplatelet agent,with the cytochromes P450显示文摘 | Eckstein JA Farid NA | 2006 | Drug Metab Dispos2006，34，4： | 1 |
| 9 | Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450显示文摘 | Rehmel JL Eckstein JA Farid NA | 2006 | Drug Metab Dispos2006，34，： | 1 |
| 10 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrei and clopidogrel 显示文摘 | Small DS Farid NA Payne CD | 2008 | Clin Pharmacol2008，48，4： | 1 |
| 11 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetic and pharmacodynamics of prasugrel and clopidogrel 显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Pharmacol2008，48，： | 1 |
| 12 | Interactions of two major metabolites of prasugrel,a thienopyridine antiplatelet agent,with the cytochromes P450显示文摘 | Rehmel JL Eckstein JA Farid NA | 2006 | Drug Metab Dispos2006，34，4： | 1 |
| 13 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel显示文摘 | SMALL DS FARID NA PAYNE CD | 2008 | J Clin Pharmaeol2008，48，4： | 1 |
| 14 | Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 15 | Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans显示文摘 | FARID NA KURIHARA A WRIGHTON SA | 2010 | J Clin Pharm2010，50，2： | 1 |
| 16 | Cytochrome P450 3A inhibition by ketoeonazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently 显示文摘 | FARID NA PAYNE CD SMALL DS | 2007 | Clin Pharmacol Ther2007，81，5： | 1 |
| 17 | Cytochrome P4503A inhibition by ketoconazole affect sprasugreland clopi-dogrel pharmacokinetics and pharmacodynamics different-ly显示文摘 | Farid NA Payne CD Small DS | 2007 | Clin Pharmacol Ther2007，81，5： | 1 |
| 18 | Effects of the proton pump in- hibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel 显示文摘 | Small DS Farid NA Payne CD | 2008 | J Clin Pharmacol2008，48，4： | 1 |
| 19 | The disposition of prasugrel, a novel thienopyridine, in humans显示文摘 | FARID NA SMITH RL GILLESPIE TA | 2007 | Drug Metab Dispos2007，35，7： | 1 |
| 20 | Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently 显示文摘 | Farid NA Payne CD Small DS | 2007 | Clin Pharmacol Ther2007，81，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员